Stefan Schubert

Learn More
OBJECTIVE To investigate the efficacy and safety of two different budesonide formulations (effervescent tablet for orodispersible use (BET) and viscous suspension (BVS)) with different daily dosages for short-term treatment of eosinophilic oesophagitis (EoE). DESIGN Adults with active EoE (n=76) randomly received 14 days' treatment with either BET 2×1(More)
  • 1